LAVAS Study
Start date:Historic End date:
June 2014 Co-ordinated by:
NHS Lothian
Lactate, Arterial and Venous Agreement in Sepsis – LAVAS trial
Aim
To determine whether an agreement between peripheral venous and arterial lactate exists in patients presenting to an Emergency Department with sepsis.
Trial Design
A prospective observational study in a consecutive sample of eligible and consented patients in the Royal Infirmary of Edinburgh
Eligibility criteria (summary)
Patients who present to the Emergency Department with suspected sepsis
Chief Investigator
Dr Deepankar Datta
Specialist Trainee Emergency Medicine
Local PI
Dr Deepankar Datta
Specialist Trainee Emergency Medicine
Research Team
Julia Grahamslaw
Lead Research Nurse
More EMERGE Trials
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
TARGET-CTCA Trial
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)